Dental prosthetics, which include partial and complete dentures, can help people in many ways, including improving their appearance and self-esteem as well as their ability to chew food and speak clearly. The usefulness of dental prosthetics is reflected in their at least 2700 year history, during which time they have been made of materials such as bone and wood.
Modern dental prosthetics, especially the base component which contacts the dental arch, are commonly made of acrylic, other hard plastics, or metal. These prosthetics can require several initial appointments over one or two months to construct and achieve a proper fit and appearance as well as periodic adjustments to maintain a proper fit as the shape of users' dental tissues change. For example, following an extraction of many or all teeth, tissue and bone may take many months to heal. During that time, prior art dental prosthetics can suffer problems with support, stability, and retention, and can create sore spots on soft tissue because of changing fit. Furthermore, the underlying bones, particularly the mandibular arch, can continue changing for many years and require periodic refittings, possibly as often as every five to seven years. For these and other reasons, modern dental prosthetics can be prohibitively expensive for some people.
Another known problem is associated with providing efficient and efficacious means for administering a treating agent (i.e., any substance, molecule, element, compound or otherwise active ingredient operable to effect an intended benefit) to a user over an extended period of time. For example, in the medical and dental arts, doctors commonly prescribe treating agents, such as drugs and medicants, to patients for repetitive oral consumption. It is widely appreciated, however, that repetitive oral consumption presents various concerns. Foremost, where self-administered, users, such as the elderly and mentally infirm, often forget or unintentionally fail to adhere to the specified regiment and schedule. This may render the treatment ineffective and in some cases worsen the mal condition. Where manual administration is difficult, as with swallowing large pills/capsules, it is further appreciated that many users become deterred from taking the prescribed agent all together. Further, even where oral consumption is properly performed, inefficiencies, such as the “first pass effect”—the percentage of drug lost to metabolization in the liver, often result in increased costs, waste, and in some cases harmful side effects. It is appreciated that similar human error concerns exist for extended intravenous, and other forms of administration.
Due to these and other problems and disadvantages in the prior art, a need exists for a dental prosthetic device that is less expensive to make, fit, and maintain.
Such a device that can also aid provision of medicants and other agents to users would also be very beneficial.
Embodiments of the invention are defined by the claims below, not this summary. A high-level overview of various aspects of the invention is provided here to introduce a selection of concepts that are further described in the Detailed-Description section below. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used in isolation to determine the scope of the claimed subject matter. In brief, this disclosure describes, among other things, a dental prosthetic device with an integrated medicant delivery component.
The dental prosthetic device includes a base component constructed of a soft, inexpensive, remoldable material and having a contact surface and a mounting surface. The contact surface is shaped to fit over a dental arch. A harder component comprising one or more tooth-like structures is associated with the base such that when the dental prosthetic device is placed over the dental arch within a user's mouth, the harder component facilitates biting and chewing in the manner of teeth. The device may further include an intermediate component positioned approximately between the softer base and harder components in order to, for example, better support the tooth-like structures.
At least one of the tooth-like structures includes a medicant delivery component integrated therein or disposed thereon for delivery of an orally administered treating agent, such as a drug, therapeutic agent, medicant, and/or aromatic/flavor producing agent, to a user. The treating agent might also comprise a substance-indicating element that indicates the presence of a substance such as alcohol in the breath or saliva of the user. The component includes a carrier that is attachable to an exterior surface or integrated into a tooth-like structure of the dental prosthetic device. The carrier may provide a partially enclosed interior space that is defined by a plurality of planar slats within which the therapeutic agent may be disposed. Or the carrier may provide a surface on which the treating agent is coated or impregnated. The slats of the carrier and/or the therapeutic agent compound is configured to provide a desired timed or controlled release of the agent while in contact with saliva in the user's mouth.
Illustrative embodiments of the invention are described in detail below with reference to the attached drawing figures, and wherein:
a is a perspective view of the back of the medicant-delivery component shown in
a is a side elevation of a pad-type medicant-delivery component defining a plurality of discrete gaps containing a treating agent, depicted in accordance with an embodiment of the invention;
b is a side elevation of the medicant-delivery component shown in
c is a side elevation of the medicant-delivery component shown in
The subject matter of select embodiments of the invention is described with specificity herein to meet statutory requirements. But the description itself is not intended to necessarily limit the scope of claims. Rather, the claimed subject matter might be embodied in other ways to include different components, steps, or combinations thereof similar to the ones described in this document, in conjunction with other present or future technologies. Terms should not be interpreted as implying any particular order among or between various steps herein disclosed unless and except when the order of individual steps is explicitly described.
With reference to
The dental prosthetic device 10, 110 comprises a softer base component 12, 112 and a harder component 14, 114. The softer base component 12, 112 includes a contact surface 18, 118 and a mounting surface 20, 120. Referring also to
The softer base component 12, 112 may incorporate a remoldable elastomeric or thermoplastic material, such as, for example, ethylene vinyl acetate, which, when activated, such as by being warmed at ambient pressure to a relatively low temperature, such as, for example, approximately 105° C. or lower, between 85° C. and 105° C., between 50° C. and 85° C., or lower than 50° C., conforms more closely to the dental arch 122. The terms “about” or “approximately” as used herein denote deviations from the exact value by +/−10%, preferably by +/−5% and/or deviations in the form of changes that are insignificant to the function. More specifically, a relatively close fit can be achieved by warming or otherwise activating the softer base component 12, 112 and placing the contact surface 18, 118 over the dental arch 122 so that the material of the softer base component more closely conforms to the shape of the dental arch 122. Furthermore, the softer base component 18, 118 can be rewarmed or reactivated whenever necessary or desirable to remold it to the changing shape of the dental arch 122. The softer base component 12, 112 may be colored to, for example, resemble gum tissue appropriate to the user's race.
The harder component 14, 114 includes one or more tooth-like structures 34, 134 associated with the mounting surface 20, 120 of the softer base component 12, 112 such that, when the dental prosthetic device 10, 110 is placed within a user's mouth in the manner of a denture, the harder component 14, 114 facilitates biting, chewing, and speaking in the manner of natural teeth. The harder component 14, 114 may incorporate a molded acrylic material. The one or more tooth-like structures 34, 134 may be affixed to or, as shown in
The dental prosthetic device 10, 110 may be produced in a limited number of sizes, such as, for example, small, medium, and large, which provides a first order of fit. Heating or otherwise activating the softer base component 12, 112 and molding it to the user's particular dental arch provides a second order of fit. As discussed, the user can thereafter reheat or otherwise reactivate the soft base component 12, 112 to refit the device 10, 110 whenever necessary due, for example, to changing tissue shape.
In one exemplary embodiment incorporating certain of the aforementioned features, the dental prosthetic device 10, 110 may comprise the softer base component 12, 112 being constructed of a remoldable material and having the contact surface 18, 118 and the mounting surface 20, 120, with the contact surface 18, 118 being shaped to fit over the dental arch 122. The softer base component 12, 112 may be colored to resemble gum tissue. The harder component 14, 114 may comprise the one or more tooth-like structures 34, 134 partially embedded in the softer base component 12, 112 and extending beyond the mounting surface 20, 120 of the softer base component 12, 112. The one or more tooth-like structures 34, 134 are shaped and colored to resemble natural teeth. As such, when the dental prosthetic device 10, 110 is placed within a user's mouth, the harder component 14, 114 facilitates biting and chewing in the manner of natural teeth.
In another exemplary embodiment incorporating certain of the aforementioned features, the dental prosthetic device 10, 110 may comprise the softer base component being constructed of a remoldable thermoplastic material which, when warmed, conforms more closely to the dental arch 122. The softer base component 12, 112 includes the contact surface 18, 118 and the mounting surface 20, 120, with the contact surface 18, 118 being shaped to fit over the dental arch 122, and the softer base component 12, 112 being colored to resemble gum tissue. The harder component 14, 114 includes one or more tooth-like structures 34, 134 constructed of a molded acrylic material embedded in the softer base component 12, 112 and extending beyond the mounting surface 20, 120 of the softer base component 12, 112. The one or more tooth-like structures are shaped and colored to resemble natural teeth such that when the dental prosthetic device 10, 110 is placed within a user's mouth, the harder component 14, 114 facilitates biting and chewing in the manner of natural teeth.
Referring also to
With reference to
The dental prosthetic device 210 comprises the softer base component 212 and the harder component 214 as discussed above. The harder component 214 includes the one or more tooth-like structures 234 and one or more internal support structures 240 that are embedded within the softer base component 212 and may function to support the tooth-like structures 234 in relation to the softer base component 212 or to achieve or maintain a better fit within the user's mouth.
More specifically, as seen in
The tooth-like structures 234 may be made of acrylic or of a more flexible or softer material such as polyethylene or polycarbonate. The latter softer materials may wear faster than the former harder material, but it is anticipated that the relatively low cost of the device 210 (as compared to traditional dentures) will allow for more frequent replacement. The internal support structures 240 may be constructed of the same material, a more flexible or softer version of the material, or a different material than the tooth-like structures 234. In particular, at least a flexible or softer version of the material of the tooth-like structure may be desirable to minimize the risk that the internal support structures 240 may tear through the softer base component 212 in which they are embedded and come into direct contact with the user's oral tissues. Relatedly, the tooth-like structures 234 and the internal support structures 240 may be molded or otherwise formed simultaneously or at different times or as a single piece or as multiple pieces.
In one implementation, for example, the tooth-like structures 234 and the internal support structures 240 are molded simultaneously as a single piece but the tooth-like structures 234 are constructed of a harder version of a material (e.g., acrylic) and the internal support structures 240 are constructed of a softer or more flexible version of the material. This may be accomplished, for example, by creating a continuous gradient of one or more additive materials in the mold such that little or none of the additive material(s) is present in the portion of the mold corresponding to the tooth-like structures 234 and more of the additive material(s) is present in the portion of the mold corresponding to the internal support structures 240, resulting in a gradient of hardness of other characteristic(s) from the harder and/or relatively inflexible tooth-like structures 234 to the softer and/or relatively flexible internal support structures 240. Such a gradient may be created, for example, through careful positioning or orientation of the mold, the use of gravity to separate heavier or denser material from lighter or less dense material, or by creating the device 210 from the tooth-like structures 234 to the internal support structures 240 and slowly introducing more of the additive material into the latter once the former has partially cured or will otherwise no longer accept the additional additive material.
With reference now to
The treating agent 314 may compose a compound 316 operable to effect additional functionality (e.g., promote curing, control the release of the agent, or modify a cavity condition, so as to facilitate delivery/absorption, etc.). For example, the compound 316 may further include an effervescent couple used to enhance drug penetration/absorption across the buccal (inside cheek), sublingual (under the tongue), and gingival (between the lips and gum) mucosae. The preferred effervescent couple evolves gas by means of a chemical reaction triggered by exposure to saliva in the mouth. For example, a soluble acid source, such as citric acid, may be caused to react with a source of carbon dioxide that is mostly basic, such as an alkaline carbonate or bicarbonate, so as to produce carbon dioxide gas. Alternatively, a pH adjusting substance may be included in the compound 316, as it is appreciated that pH levels can influence the relative concentrations of ionized and un-ionized drug, which in turn, affects the dissolution of the drug in the saliva and absorption across the oral mucosa.
In an embodiment, the agent 314 and/or compound 316 is retained by a carrier 322 intermediately affixed to the tooth-like structure 34/134 and operable to provide a controlled release of the agent 314. As shown in
The carrier 322 comprises, and the space 324 is defined by, a plurality of polymeric planar slats 328 radially emanating from a disk base 332. The base 332 is indiscriminately circular in the illustrated embodiment, and defines an insertion hole 334 for receiving the agent 314. A plurality of radially open sectors 336 may be defined adjacent the perimeter of the base 332 for added access to and from the space 324 (
As such, once in place, saliva is allowed to flow into the space 324 and interact with the agent 314/compound 316, so as to release the agent 314 in a controlled manner. That is to say, the agent 314/compound 316 may be configured to chemically react with, or be slowly dissolved by saliva at a rate configured to affect a desired time release. For example, the compound 316 may present or the agent 314 may be otherwise retained by hydrolysable bonds that break when exposed to the water content of saliva. To release the agent 314 at a different rate, the constituency of the compound 316 may be changed such that the bonds become hydrolyzed at a different rate. Alternatively, the agent 314 may compose a gel, or other high viscosity fluid operable to affect the desired time release, through shearing due to gravity.
In one embodiment, the agent 314 is disposed within a porous medium, such as a polymer matrix configured to allow the agent 314 to escape or diffuse therefrom at a controlled rate. The porous medium may be installed inside the carrier 322 within the space 324 behind the planar slats 328, or the planar slats 328 might be omitted because they are not necessary to control the diffusion rate of the agent 314. For example, the porous medium comprising the carrier 322 in
The gaps 330 and planar slats 328 may be adjustable, so as to vary the rate of seepage and therefore time release, for example, by pushing down on the apex to cause resistively bendable planar slats 328 to spread radially. Alternatively, the component 312 may further include a manually shiftable outer cover (not shown) that shifts between exposed and closed positions, such that the agent 314 is exposed to the oral cavity 320 and released only when the cover is in the exposed position.
In another embodiment, the agent 314 or compound 316 may be coated onto the carrier 322 (
In another embodiment depicted in
The medicant-delivery component 312 may extend across the full width of the tooth-like structure 34/134 (
The medicant-delivery component 312 may be removable from the tooth-like structure 34/134 to enable insertion of the agent 314 or compound 316 therein. For example, the medicant-delivery component 312 may be slideable in an axial direction within a bore in the tooth-like structure 34/134 in which the component 312 is disposed. Or the component 312 may remain integral with the tooth-like structure 34/134 during installation of the agent 314/compound 316. In one embodiment, the tooth-like structure 34/134 is removable from the dental prosthetic device 10, 110 to aid installation of the agent 314/compound 316. As depicted in
With reference now to
The matrix material may be dissolvable over the period, so as to gradually expose the interior gaps 350 to the releasing conditions of the cavity 320 (
Especially where the agent 314 presents a prescription strength drug or medicant, the component 312 is intended for insertion or attachment (and removal where necessary) by a trained healthcare provider. In a dental setting, for example, the carrier 322 may be bonded to at least one tooth-like structure 34/134 by applying a quantity of a preloaded dental composite material 352 (e.g., a glass ionomer) intermediate the carrier 322 and tooth-like structure 34/134 (
It is certainly within the ambit of the present invention, however, for the user 318 to self-apply an over-the-counter component 312, particularly where the agent 314 is aromatic or flavor producing. For example, the component 312 may comprise a pad-type implantation component 354 formed of a dissolvable matrix impregnated with an aromatic and/or flavor producing agent may be adhered to an interior lateral surface 346 of the tooth-like structures 34/134, so as to be adjacent the tongue region best suited to taste the flavor. In
With additional reference to
In operation, the medicant-delivery component 312 is affixed relative to one or more of the tooth-like structures 34/134 of the maxillary or mandibular dental prosthetic devices 10/110. The component 312 stays in place autonomously, as opposed to being held in place by clenching the jaw or devices 10/110, which distinguishes the invention from trays, mouthpieces, and the like. The component 312 functions to deliver the agent 314 to a remainder portion of the user 318 so as to be further distinguishable from whitening strips, and the like, which deliver an agent directly to the teeth. It is appreciated that the bond or holding strength between the component 312 and engaged tooth-like structure 34/134 is such that the component 312 does not dislodge under stresses caused during normal operation of the mouth (e.g., tooth brushing, consumption of food and beverages, speaking, etc.). Moreover, the component 312 is configured such that fluid interaction with anticipatory elements and ingredients commonly introduced within the mouth, including fluoride in toothpaste, does not substantially impact the rate of time release or otherwise alter the component 312.
As shown in
As a result of releasing the agent 314 over the period, the agent 314 is delivered systemically or locally to a remainder portion (e.g., the bloodstream, gums, etc.) of the user 318. Once depleted over the period, the component 312 may be removed and replaced, or refilled in place. An efficient method of delivering a drug or medicant agent 314 to the user 318 is through the mucous membrane lining within the cavity 320. The invention functions to that end by releasing the agent 314, so as to be absorbed across the lining.
In another embodiment, the treating agent 314 is configured not for release and treatment of the user, but rather as an indicator of substances that may be present in the oral cavity 320 of the user. For example, the agent 314 may configured to react with and/or indicate the presence of alcohol, drugs, or other substances in the saliva or breath of the user. In one embodiment, the agent 314 provides an indication that the blood-alcohol content of the user is above at least a minimum level, such as by reacting with ethanol concentrations present in the breath or saliva of the user. When in the presence of such a substance, the treating agent 314 may provide a visible color change that can be viewed by a user or third party. The color change may be permanent so as to provide a record of exposure or may be reversible to allow continued or repeated use of the agent 314 and/or component 312.
In one embodiment, the component 312 includes one or more electronic sensors configured to detect the presence of alcohol, drugs, or other substances in the saliva or breath of the user. The component 312 may also be configured to communicate wirelessly or through a wired connection an indication of conditions sensed in the oral cavity. For example, the component 312 might communicate an indication to a receiving device when a blood alcohol level above a predetermined level is detected. In such an instance, the component 312 may be configured as an active or passive RFID (radio frequency identification) device or may include appropriate electronic systems to enable communications such as via BLUETOOTH, NFC (near field communications), or other wireless communication systems. The receiving device may include any device configured to receive wireless communications including, for example, a dedicated reader, a smart phone, or a desktop, laptop, or tablet computer, among a variety of other devices. The component 312 may alternatively or additionally store data in a memory that is indicative of the sensed conditions within the oral cavity 320. The stored data may be downloaded from the memory by communicatively coupling the component 312 to a computing device through a wired connection when the prosthetic device 10/110 is removed from the oral cavity 320.
Many different arrangements of the various components depicted, as well as components not shown, are possible without departing from the scope of the claims below. Embodiments of the technology have been described with the intent to be illustrative rather than restrictive. Alternative embodiments will become apparent to readers of this disclosure after and because of reading it. Alternative means of implementing the aforementioned can be completed without departing from the scope of the claims below. Identification of structures as being configured to perform a particular function in this disclosure and in the claims below is intended to be inclusive of structures and arrangements or designs thereof that are within the scope of this disclosure and readily identifiable by one of skill in the art and that can perform the particular function in a similar way. Certain features and sub-combinations are of utility and may be employed without reference to other features and sub-combinations and are contemplated within the scope of the claims.
This application is a continuation-in-part of U.S. patent application Ser. No. 13/385,381, filed Feb. 16, 2012, which is a continuation-in-part of U.S. patent application Ser. No. 13/066,202, filed Apr. 8, 2011. This application is also a continuation-in-part of U.S. patent application Ser. No. 14/250,384 filed Apr. 11, 2014. The disclosures of each of these prior applications are hereby incorporated herein in their entirety by reference.
Number | Date | Country | |
---|---|---|---|
Parent | 13385381 | Feb 2012 | US |
Child | 14698604 | US | |
Parent | 13066202 | Apr 2011 | US |
Child | 13385381 | US | |
Parent | 14250384 | Apr 2014 | US |
Child | 13066202 | US |